Two opposing roles of O-glycans in tumor metastasis
- 19 March 2012
- journal article
- review article
- Published by Elsevier BV in Trends in Molecular Medicine
- Vol. 18 (4), 224-232
- https://doi.org/10.1016/j.molmed.2012.02.001
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (P01CA71932, R01CA3000)
- Japan Society for the Promotion of Science (22570131, B22390301)
- Ministry of Education, Culture, Sports, Science and Technology (21791483)
- Japan Science and Technology Agency
- Core Research for Evolutional Science and Technology
This publication has 82 references indexed in Scilit:
- Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccineProceedings of the National Academy of Sciences of the United States of America, 2011
- Mammalian O-mannosylation: unsolved questions of structure/functionCurrent Opinion in Structural Biology, 2011
- A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycansThe EMBO Journal, 2011
- Core 2 N‐acetylglucosaminyltransferase‐1 expression induces aggressive potential of testicular germ cell tumorInternational Journal of Cancer, 2010
- Altered NK Cell Development and Enhanced NK Cell-Mediated Resistance to Mouse Cytomegalovirus in NKG2D-Deficient MiceImmunity, 2009
- Tumor suppressor function of laminin-binding α-dystroglycan requires a distinct β3- N -acetylglucosaminyltransferaseProceedings of the National Academy of Sciences of the United States of America, 2009
- Up on the tightrope: natural killer cell activation and inhibitionNature Immunology, 2008
- NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous MalignancyImmunity, 2008
- Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAILNature Medicine, 2007
- Mucin‐type O‐glycans in human colon and breast cancer: glycodynamics and functionsEMBO Reports, 2006